EAM Investors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-38,555
| Closed | -$1.87M | – | 264 |
|
|
2020
Q2 | $1.87M | Buy |
+38,555
| New | +$1.87M | 0.41% | 98 |
|
|
2020
Q1 | – | Sell |
-49,891
| Closed | -$2.13M | – | 206 |
|
|
2019
Q4 | $2.13M | Buy |
49,891
+2,329
| +5% | +$99.6K | 0.47% | 71 |
|
|
2019
Q3 | $1.71M | Buy |
+47,562
| New | +$1.71M | 0.45% | 88 |
|
|
2016
Q3 | – | Sell |
-66,537
| Closed | -$2.16M | – | 294 |
|
|
2016
Q2 | $2.16M | Buy |
+66,537
| New | +$2.16M | 0.32% | 168 |
|
|
2014
Q2 | – | Sell |
-46,875
| Closed | -$1.14M | – | 320 |
|
|
2014
Q1 | $1.14M | Sell |
46,875
-2,460
| -5% | -$59.8K | 0.21% | 276 |
|
|
2013
Q4 | $1.23M | Sell |
49,335
-30,005
| -38% | -$750K | 0.22% | 247 |
|
|
2013
Q3 | $2.18M | Sell |
79,340
-72,715
| -48% | -$2M | 0.43% | 60 |
|
|
2013
Q2 | $2.76M | Buy |
+152,055
| New | +$2.76M | 0.6% | 28 |
|